ArticleArchives of rheumatology2021

The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients.

Veli Yazısız et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.